The World of Health & Medicine News

Same Symptoms, Different Care: How AI’s Hidden Bias Alters Medical Decisions

Same Symptoms, Different Care: How AI’s Hidden Bias Alters Medical Decisions

AI tools designed to assist in medical decisions may not treat all patients equally. A new study shows that these systems sometimes alter care recommendations based on a patient’s background, even when their medical conditions are identical.

Researchers at Mount Sinai tested leading generative AI models and found inconsistencies in treatment suggestions depending on socioeconomic and demographic information, highlighting a major challenge in building fair and reliable AI for healthcare.

As artificial intelligence (AI) becomes more integrated into health care, a new study from the Icahn School of Medicine at Mount Sinai shows that generative AI models can recommend different treatments for the same medical condition, based solely on a patient’s socioeconomic or demographic background.

Published online today (April 7, 2025) in Nature Medicine, the study underscores the need for early testing and oversight to make sure AI-driven care is fair, effective, and safe for everyone.

spot_img

Explore more

spot_img

Scientists Discover Promising New Alzheimer’s Treatment

Scientists Discover Promising New Alzheimer’s Treatment Researchers at Case Western Reserve University have developed a drug that protects the “guardian of the brain.” More than 55...

Harvard seeks end to US funding cuts, says national security, public...

Harvard seeks end to US funding cuts, says national security, public health research in peril  Harvard University asked a federal judge on Monday to issue...

Gilead’s CAR-T cell therapy shows promise in deadly brain cancer

Gilead's CAR-T cell therapy shows promise in deadly brain cancer A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in...

Bird Flu Is Now Killing Cats at a 90% Fatality Rate...

Bird Flu Is Now Killing Cats at a 90% Fatality Rate – Experts Warn It Could Jump to Humans Spring is here, birds are on...

Amgen drug cuts small cell lung cancer death risk by 40%

Amgen drug cuts small cell lung cancer death risk by 40% Amgen's (AMGN.O), opens new tab Imdelltra reduced the risk of death by 40% compared to chemotherapy...

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug...

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug partnership Bristol Myers Squibb (BMY.N), opens new tab will pay $1.5 billion upfront to partner with...

US FDA approves Moderna’s next-generation COVID vaccine for adults 65 or...

US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older The U.S. Food and Drug Administration has approved Moderna's (MRNA.O), opens new tab next-generation COVID-19...

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer...

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds Treating breast cancer patients with AstraZeneca's (AZN.L), opens new tab experimental pill camizestrant...